A Stanford-led team discovered a new ketosis pathway involving BHB-amino acids, shedding light on its effects like appetite ...

Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...

Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug ...

Nirmuli plants are known for their rich iron content, earning the herb a place in ayurvedic medicine as a dietary supplement ...

New Bachelor of Science in biomedical sciences at UT Dallas offers a comprehensive curriculum that prepares students for a ...

Frontiers for Young Minds (FYM), an award-winning science engagement journal for kids, is proud to share three new articles ...

Dr. Bob S. Carter — a veteran health care administrator and brain surgeon — will direct the sprawling University of Utah ...

For over 30 years, Schrödinger—named after the Nobel Prize-winning physicist Erwin Schrödinger—has been providing ...

Inspired by her personal experiences with the health care system, Narrative Medicine alum JaVe Bonner is working on an app ...

In a world grappling with a multitude of health threats -; ranging from fast-spreading viruses to chronic diseases and drug-resistant bacteria -; the need for quick, reliable, and easy-to-use home ...

Robert Lefkowitz was one of more than 75 Nobel Prize winners to sign the letter against President-elect Trump’s nomination of ...

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. ...